South-East Asia (WHO region) vs Uzbekistan: Measles-containing-vaccine second-dose (MCV2) immunization coverage

South-East Asia (WHO region)
93.0%
in 2025
Uzbekistan
99.0%
in 2025
South-East Asia (WHO region) rank
1st
Uzbekistan rank
1st

Measles-containing-vaccine second-dose (MCV2) immunization coverage over time

  • South-East Asia (WHO region)
  • Uzbekistan
020406080100200020122025

How they compare

Uzbekistan currently reports 99.0% against 93.0% in South-East Asia (WHO region), a difference of 6.0%.

That makes Uzbekistan's figure about 1.1 times South-East Asia (WHO region)'s.

Across all 26 years both countries report, Uzbekistan has been ahead every year.

South-East Asia (WHO region) ranks 1st and Uzbekistan ranks 1st of 11 groups.

Uzbekistan has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade South-East Asia (WHO region) Uzbekistan Difference Ahead
2000s 4.2% 71.2% 67.0% Uzbekistan
2010s 59.5% 94.5% 35.0% Uzbekistan
2020s 88.3% 99.0% 10.7% Uzbekistan

Averages of every year both report within each decade.

Frequently asked questions

Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, South-East Asia (WHO region) or Uzbekistan?
Uzbekistan, at 99.0% against 93.0% in South-East Asia (WHO region) as of 2025.
What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between South-East Asia (WHO region) and Uzbekistan?
6.0%, with Uzbekistan ahead.
How many years of comparable data are there for South-East Asia (WHO region) and Uzbekistan?
26 years are reported by both, from 2000 to 2025.
How do South-East Asia (WHO region) and Uzbekistan rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
South-East Asia (WHO region) ranks 1st and Uzbekistan ranks 1st of 11 groups.
Where does this data come from?
World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

South-East Asia (WHO region) vs Uzbekistan: Measles-containing-vaccine second-dose (MCV2) immunization coverage. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 15 September 2026, from https://health.statizoid.com/compare/measles-containing-vaccine-second-dose-mcv2-immunization-coverage-by-the-locally/south-east-asia-who-region/uzbekistan/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/measles-containing-vaccine-second-dose-mcv2-immunization-coverage-by-the-locally/south-east-asia-who-region/uzbekistan/">South-East Asia (WHO region) vs Uzbekistan: Measles-containing-vaccine second-dose (MCV2) immunization coverage</a> — Statizoid

About this data

Indicator
Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
207 places, 5,363 data points, 2000–2025
Last refreshed